pneumonia
defin
pneumonia
patient
treat
mechan
ventil
occur
hr
intub
pneumonia
common
hospit
acquir
infect
intens
care
patient
occur
intub
patient
chastr
fagon
rello
et
al
pneumonia
associ
high
mortal
rang
depend
microorgan
involv
chastr
fagon
apart
high
mortal
associ
pneumonia
demonstr
pneumonia
prolong
durat
mechan
ventil
stay
intens
care
unit
chastr
fagon
rello
et
al
pneumonia
caus
bacteria
pseudomona
aeruginosa
staphylococcu
aureu
chastr
fagon
howev
use
criteria
describ
previous
baselski
allaouchich
et
al
approxim
patient
suspect
pneumonia
bacteri
pneumonia
confirm
microbiolog
often
caus
infect
found
remain
patient
suspect
pneumonia
recent
year
virus
suggest
caus
respiratori
infect
critic
ill
patient
acanthamoeba
polyphaga
mimiviru
apmv
giant
viru
discov
belong
microorgan
raoult
et
al
microorgan
legionella
pneumophila
known
caus
pneumonia
differ
patient
group
variou
studi
suggest
possibl
pathogen
apmv
seroconvers
apmv
shown
patient
pneumonia
la
scola
et
al
nosocomi
pneumonia
berger
et
al
studi
antibodi
apmv
found
respect
patient
includ
addit
patient
pneumonia
posit
serolog
apmv
associ
increas
durat
mechan
ventil
stay
intens
care
unit
vincent
et
al
viru
found
one
patient
one
particular
studi
la
scola
et
al
potenti
role
apmv
respiratori
pathogen
signific
proport
patient
suspect
pneumonia
without
caus
microorgan
found
aim
present
studi
assess
presenc
apmv
bronchoalveolar
lavag
fluid
sampl
critic
ill
patient
suspect
pneumonia
pcr
retrospect
studi
conduct
intens
care
unit
maastricht
univers
medic
centr
maastricht
netherland
hospit
consecut
bronchoalveolar
lavag
fluid
sampl
obtain
januari
octob
patient
suspect
pneumonia
elig
inclus
clinic
suspicion
pneumonia
defin
describ
bonten
et
al
pneumonia
confirm
microbiolog
defin
admiss
intens
care
unit
least
hr
prior
bal
collect
total
quantit
cultur
result
cfuml
andor
cell
intracellular
organ
baselski
allaouchich
et
al
collect
data
includ
patient
demograph
characterist
age
gender
clinic
data
apach
ii
score
reason
perform
bronchoalveolar
lavag
diagnosi
upon
admitt
admitt
intens
care
unit
ward
smoke
length
intens
care
unit
stay
perform
bronchoalveolar
lavag
total
length
stay
intens
care
unit
total
length
hospit
stay
mortal
diagnosi
examin
diagnosi
pulmonari
diseas
bronchoalveolar
lavag
laboratori
data
concern
bronchoalveolar
lavag
fluid
total
cell
count
differenti
cell
count
presenc
ciliat
epitheli
cell
squamou
epitheli
cell
reactiv
pneumocyt
type
ii
linssen
et
al
quantit
cultur
result
bronchoalveolar
lavag
fluid
sampl
reject
recov
volum
less
ml
total
cell
count
less
cellsml
prepar
show
excess
amount
intercellular
debri
damag
nucleat
cell
squamou
epitheli
cell
bronchoscopi
subsequ
lavag
perform
describ
previous
linssen
et
al
bronchoalveolar
lavag
fluid
sampl
transport
laboratori
within
min
collect
process
immedi
upon
arriv
microbiolog
laboratori
first
fraction
bronchoalveolar
lavag
fluid
repres
bronchial
fraction
use
mycobacterium
spp
cultur
andor
pcr
remain
three
fraction
alveolar
fraction
pool
total
cell
count
perform
use
fuch
rosenth
haemocytomet
chamber
quantit
bacteri
cultur
perform
describ
previous
jacob
et
al
cytocentrifug
prepar
de
brauwer
et
al
stain
giemsa
stain
gram
stain
differenti
cell
count
de
brauwer
et
al
perform
includ
number
cell
intracellular
organ
reactiv
type
ii
pneumocyt
linssen
et
al
sampl
ml
centrifug
min
divid
sampl
cell
supernat
supernat
store
tube
ml
cell
resuspend
ml
mixtur
eagl
minim
essenti
medium
dimethyl
sulfoxid
store
tube
ml
futur
use
identifi
possibl
infecti
sourc
apmv
hospit
total
water
sampl
l
collect
sampl
includ
water
sampl
obtain
tap
locat
intens
care
unit
sampl
cool
tower
suppli
water
hospit
sampl
filter
polycarbon
filter
sartoriu
stedim
biotech
goettingen
germani
afterward
filter
place
ml
steril
water
sonic
min
sonic
bath
bandelin
electron
gmbh
co
kg
berlin
germani
khz
total
store
bronchoalveolar
lavag
cell
fraction
ml
filter
water
sampl
use
dna
isol
use
genom
dna
purif
kit
promega
madison
wi
purifi
dna
resuspend
final
volum
sampl
spike
control
plasmid
murin
cytomegaloviru
glycoprotein
b
gene
vliegen
et
al
dna
isol
isol
amplif
control
pcr
perform
use
primer
probe
design
softwar
target
mimi
vv
helicas
gene
tabl
assay
perform
optic
reaction
plate
appli
biosystem
foster
citi
ca
total
volum
contain
forward
primer
revers
primer
probe
absolut
qpcr
mastermix
abgen
epsom
uk
dna
pcr
reaction
isol
amplif
control
carri
use
primer
probe
describ
previous
vliegen
et
al
pcr
thermal
profil
apmv
consist
initi
incub
min
follow
total
cycl
amplif
sec
min
amplif
perform
use
abi
sequenc
detect
system
data
interpret
use
abi
sd
softwar
posit
control
contain
apmv
suppli
professor
raoult
raoult
et
al
posit
control
includ
pcr
run
dna
isol
cultur
apmv
evalu
use
spectrophotomet
nanodrop
spectrophotomet
isogen
life
scienc
de
meern
netherland
determin
concentr
puriti
sampl
standard
curv
gener
use
serial
dilut
copiesml
test
perform
cultur
apmv
resuspend
nacl
bronchoalveolar
lavag
fluid
tap
water
spike
apmv
amplif
effici
calcul
use
abi
sd
softwar
show
effici
determin
detect
limit
serial
dilut
test
lower
limit
detect
establish
copiesml
copiespcr
specif
assay
test
use
common
respiratori
virus
rna
dna
virus
virus
includ
influenza
b
rsv
hmpv
coronaviru
rhinoviru
cmv
test
neg
pcr
determin
repeat
serial
dilut
bronchoalveolar
lavag
fluid
copyml
test
technician
independ
experi
apmv
dilut
detect
variat
ct
valu
five
serial
dilut
bronchoalveolar
lavag
fluid
test
four
time
two
differ
technician
show
repeat
high
januari
octob
bronchoalveolar
lavag
fluid
sampl
elig
inclus
total
sampl
exclud
studi
insuffici
materi
avail
sampl
exclud
sampl
met
exclus
criteria
final
total
sampl
patient
includ
tabl
ii
show
demograph
data
patient
includ
sampl
includ
clinic
suspect
episod
pneumonia
episod
patient
confirm
microbiolog
tabl
iii
show
caus
microorgan
episod
multipl
microorgan
found
bronchoalveolar
lavag
fluid
microorgan
present
quantiti
cfuml
baselski
allaouchich
et
al
consid
caus
microorgan
microorgan
isol
frequent
enterobactericea
tabl
iii
sampl
includ
test
retrospect
presenc
cytomegaloviru
yield
posit
sampl
apmv
dna
detect
bronchoalveolar
lavag
fluid
sampl
test
apmv
dna
also
detect
water
sampl
collect
hospit
cool
tower
water
tap
intens
care
unit
present
studi
apmv
dna
detect
bronchoalveolar
lavag
fluid
sampl
critic
ill
patient
suspect
pneumonia
anim
studi
perform
khan
et
al
shown
apmv
abl
induc
histolog
evid
pneumonia
format
diffus
alveolar
damag
mice
sinc
viru
abl
induc
pneumonia
mice
hypothes
would
also
abl
induc
pneumonia
human
sever
studi
conduct
detect
apmv
dna
differ
patient
group
larcher
et
al
dare
et
al
evid
apmv
respiratori
pathogen
base
mainli
serolog
studi
la
scola
et
al
perform
studi
canada
show
presenc
antibodi
apmv
patient
pneumonia
berger
et
al
collect
blood
sampl
patient
admit
intens
care
unit
suspect
clinic
pneumonia
total
episod
pneumonia
includ
antibodi
apmv
detect
patient
anoth
studi
perform
intens
care
unit
determin
apmv
admit
patient
vincent
et
al
patient
suspicion
pneumonia
sampl
acut
serum
sampl
test
presenc
antibodi
apmv
immunofluoresc
assay
total
intens
care
unit
patient
suspicion
pneumonia
apmv
furthermor
apmv
associ
increas
durat
mechan
ventil
stay
intens
care
unit
studi
show
possibl
role
apmv
respiratori
infect
howev
presenc
antibodi
apmv
prove
activ
infect
caus
viru
order
establish
causal
link
apmv
pulmonari
infect
criteria
describ
articl
robinson
could
use
specif
criteria
base
koch
postul
adapt
fit
major
virus
criteria
state
viru
present
respiratori
specimen
signific
percentag
patient
suspicion
infect
absent
major
healthi
peopl
mere
presenc
antibodi
show
individu
contact
viru
alway
impli
diseas
result
present
studi
line
two
previou
studi
apmv
dna
could
detect
neither
patient
pneumonia
patient
pneumonia
nasal
nasopharyng
aspir
nine
differ
consist
patient
dare
et
al
patient
includ
present
studi
critic
ill
patient
suspicion
pneumonia
oppos
studi
perform
dare
et
al
consequ
may
fulli
compar
patient
materi
pcr
perform
also
differ
present
studi
use
bronchoalveolar
lavag
fluid
sampl
whilst
pcr
studi
dare
et
al
conduct
nasal
nasopharyng
aspir
studi
conduct
larcher
et
al
total
nasopharyng
aspir
children
hospit
respiratori
tract
infect
test
presenc
differ
respiratori
virus
includ
apmv
apmv
could
detect
respiratori
sampl
test
pcr
one
studi
current
describ
patient
apmv
dna
detect
bronchoalveolar
lavag
specimen
la
scola
et
al
perform
studi
canadian
popul
consist
patient
diagnos
pneumonia
healthi
control
patient
apmv
detect
critic
ill
patient
two
episod
pneumonia
hospit
apmv
dna
detect
sampl
second
episod
unfortun
serum
test
presenc
antibodi
apmv
patient
sinc
apmv
detect
second
episod
suspect
pneumonia
suggest
acquir
hospit
probabl
water
present
intens
care
unit
sinc
apmv
isol
singl
patient
clinic
respiratori
infect
la
scola
et
al
apmv
might
major
caus
respiratori
infect
intens
care
patient
howev
remark
made
concern
neg
pcr
result
present
studi
sinc
discoveri
descript
first
ampv
strain
mani
virus
detect
probe
use
present
studi
match
ampv
mamaviru
close
relat
virus
mimiviru
famili
therefor
patient
present
studi
could
posit
virus
mimiviru
famili
sinc
virus
mimiviru
famili
prone
polymorph
nucleotid
level
design
univers
pcr
model
high
sensit
complet
mimiviru
famili
difficult
one
limit
present
studi
lack
serolog
result
patient
therefor
extent
exposur
studi
patient
apmv
yet
unravel
likewis
author
best
knowledg
seropreval
antibodi
apmv
gener
dutch
popul
also
known
make
imposs
predict
popul
risk
possibl
apmv
infect
anoth
limit
might
retrospect
natur
studi
due
durat
studi
bronchoalveolar
lavag
fluid
sampl
store
frozen
long
time
might
alter
composit
bronchoalveolar
lavag
fluid
sampl
third
limit
studi
amount
exclud
bronchoalveolar
lavag
fluid
sampl
due
amount
test
alreadi
perform
bronchoalveolar
lavag
fluid
sampl
diagnost
research
purpos
proport
sampl
contain
enough
materi
perform
dna
extract
apmv
correctli
although
suspect
apmv
appear
present
studi
critic
ill
patient
suspect
pneumonia
therefor
apmv
seem
frequent
caus
pneumonia
